Which blood glucose test strips are best? According to the Centers for Disease Control, over 30 million Americans have diabetes and nearly 98 million have prediabetes. Measuring blood glucose levels ...

October 16, 2006 — The US Food and Drug Administration (FDA) and LifeScan, a Johnson & Johnson company, have notified healthcare professionals and consumers against the use of counterfeit blood ...

Abbott announced that the FDA has cleared its FreeStyle Lite blood glucose test strips. FreeStyle Lite test strips do not use the GDH-PQQ enzyme, which can be affected by common non-glucose sugars (eg ...

Diabetes tests are expected to reach record sales due to the disease's epidemic proportions. The global market for blood glucose test strips will be worth $12.93 billion in 2021, its highest ever ...

FDA has announced the recommendation that use of Shasta Technologies' GenStrip Glucose Test Strips be discontinued immediately and remaining stocks be removed from store shelves. The strips are ...

diabetes test strip Trividia Health (formerly Nipro Diagnostics) announced a voluntary recall of certain lots of TRUEread, TRUEtrack, and TRUEtest blood glucose test strips after determining that some ...

The government warned diabetics Friday to watch for counterfeit versions of test strips commonly used to monitor blood sugar levels. The test strips, for use in glucose monitors made by a Johnson & ...

Even when things go well, managing diabetes is not easy. Keeping tabs on this disease 24/7 takes planning, commitment, support, and the right tools. For years, a chief complaint among those living ...

(Corrected) Abbott Diabetes Care has issued a recall of its FreeStyle Flash Blood Glucose Monitoring System and FreeStyle Blood Glucose Monitoring System. In addition, users of the Omnipod Insulin ...

Abbott Park, Ill.-based Abbott has issued a nationwide recall of 20 lots of FreeStyle and FreeStyle Lite Blood Glucose Test Strips, according to a news release. The lots of recalled test strips may ...

Routine self-monitoring of blood glucose levels by people with type 2 diabetes who are not taking insulin is an ineffective use of health resources as the modest benefits are outweighed by the ...